GL
XENT

GLG LLC’s Intersect ENT, Inc XENT Stock Holding History

GLG LLC’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-69,799
Closed -$1.63M – 604
2015
Q3 		$1.63M Sell
69,799
-612
-0.9% -$16.9K 0.04% 340
2015
Q2 		$2.02M Buy
+70,411
New +$1.85M 0.04% 352

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GLG LLC's XENT Position: Q4 2015 in Review

GLG LLC sold out of Intersect ENT, Inc (XENT) in Q4 2015, closing a stake of 69,799 shares — an estimated $1.63M sold.

GLG LLC first reported a position in XENT in Q2 2015 and held it in 2 quarters. The position peaked at $2.02M in Q2 2015. 115 funds tracked by Wall St. Rank hold XENT as of Q4 2015.

  • GLG LLC reported no remaining Intersect ENT, Inc position as of Q4 2015 after selling out during the quarter.
  • GLG LLC sold 69,799 Intersect ENT, Inc shares in Q4 2015, an estimated $1.63M.
  • GLG LLC first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 2 quarters.
  • GLG LLC's Intersect ENT, Inc position peaked at $2.02M in Q2 2015.
  • 115 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2015.

Based on GLG LLC's 13F filing for Q4 2015, filed 16 Feb 2016.